Summary
Effective 2026-12-01, the Nebraska Medicaid (UnitedHealthcare Community Plan) medical benefit drug Maximum Dosage and Frequency policy was revised: the list of maximum allowed quantities and frequencies by HCPCS units was updated, Exdensur (depemokimab) and Spinraza (nusinersen) were added, HCPCS codes J2326 and J2361 were added, and the descriptions for Q5136 and Q5157 were revised. Claims for these drugs billed above the listed per-administration units or frequency limits will be subject to the plan's limits, so the practice should align dosing and unit entry with the updated list.
Get alerts when payers change rules like this one
We check UnitedHealthcare and other payers every day and email you when a change matches your specialty and state.